Related Experiment Video
Updated: Jul 5, 2026
09:33
Preparation Of Neovascular Tissues from Human Glioma Tissues for Quantitative Proteomics Analysis of Tumor Angiogenesis
Published on: March 20, 2026
Paraganglioma: a potentially challenging tumor
Mark Trombetta1, Jan Silverman, Athanasios Colonias
1Department of Radiation Oncology, Allegheny General Hospital, Pittsburgh, Pennsylvania 15212, USA. mtrombet@wpahs.org
Oncology (Williston Park, N.Y.)
|May 23, 2008
Summary
Paragangliomas are typically benign tumors. Metastatic paraganglioma is rare and challenging, requiring a review of current therapeutic options for this unusual disease.
Area of Science:
- Oncology
- Neurosurgery
Background:
- Paragangliomas are generally low-grade neoplasms with a benign clinical course.
- Treatment for paraganglioma has evolved, with surgery and radiotherapy as standard primary therapies.
- Stereotactic radiosurgery is a more recent, effective treatment for this rare tumor.
Observation:
- Metastatic disease in paraganglioma patients is infrequent and poses significant clinical challenges.
- This report details a case of metastatic paraganglioma and reviews its unique characteristics.
Findings:
- The natural history of paraganglioma is usually benign.
- Metastatic paraganglioma represents an unusual and difficult clinical scenario.
- Multiple therapeutic strategies exist for managing metastatic paraganglioma.
Implications:
- Understanding the features of metastatic paraganglioma is crucial for effective management.
- A comprehensive review of therapeutic options is necessary for challenging cases.
- This case highlights the importance of considering diverse treatment modalities for rare oncological conditions.
